196 related articles for article (PubMed ID: 9825853)
1. Late luteal rescue in the baboon (Papio cynocephalus).
Castracane VD; Stevens V; Knickerbocker J; Powell J; Randolph M; Gimpel T
Hum Reprod Update; 1998; 4(4):383-8. PubMed ID: 9825853
[TBL] [Abstract][Full Text] [Related]
2. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
3. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
4. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
5. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
6. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
Ottobre JS; Stouffer RL
Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
[TBL] [Abstract][Full Text] [Related]
7. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
8. The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle.
Soules MR; Bremner WJ; Dahl KD; Rivier JE; Vale WW; Clifton DK
Am J Obstet Gynecol; 1991 Apr; 164(4):989-94; discussion 994-6. PubMed ID: 2014851
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of both luteal and pituitary function in baboons with nafarelin, a potent LH-RH agonist.
Vickery BH; Powell J; Stevens VC
Int J Fertil; 1988; 33(3):188-93. PubMed ID: 2899565
[TBL] [Abstract][Full Text] [Related]
10. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
11. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
[TBL] [Abstract][Full Text] [Related]
12. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
13. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
[TBL] [Abstract][Full Text] [Related]
14. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
15. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.
Mais V; Kazer RR; Cetel NS; Rivier J; Vale W; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1250-5. PubMed ID: 3084538
[TBL] [Abstract][Full Text] [Related]
16. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
17. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
Gonen Y; Balakier H; Powell W; Casper RF
J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
[TBL] [Abstract][Full Text] [Related]
18. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modulation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during simulated early pregnancy.
Duffy DM; Hutchison JS; Stewart DR; Stouffer RL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2307-13. PubMed ID: 8964869
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of exogenous human chorionic gonadotrophin on progesterone production from normal or malfunctioning corpus luteum.
Momoeda M; Tsutsumi O; Morita Y; Igarashi T; Suenaga A; Osuga Y; Shiotsu H; Yano T; Taketani Y
Hum Reprod; 1998 Jul; 13(7):1907-11. PubMed ID: 9740447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
